SEMAFORE PHARMACEUTICALS
Semafore Pharmaceuticals discovers and develops clinical-stage drugs.
SEMAFORE PHARMACEUTICALS
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2000-01-01
Address:
Indianapolis, Indiana, United States
Country:
United States
Website Url:
http://www.semaforepharma.com
Status:
Active
Total Funding:
13.5 M USD
Technology used in webpage:
Content Delivery Network OpenResty
Similar Organizations
Fedora Pharmaceuticals
Fedora Pharmaceuticals engages in the discovery and development of antibiotics for life-threatening microbial drug resistance needs.
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Pharmathen
Pharmathen is a private pharmaceutical company developing generic drugs.
Synaptic Pharmaceuticals
Synaptic Pharmaceuticals develops human receptor-targeted drug design technology.
Investors List
Twilight Venture Partners
Twilight Venture Partners investment in Series B - Semafore Pharmaceuticals
Official Site Inspections
http://www.semaforepharma.com
- Host name: 104.247.81.53
- IP address: 104.247.81.53
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto

More informations about "Semafore Pharmaceuticals"
Semafore Pharmaceuticals - Crunchbase Company Profile & Funding
Semafore Pharmaceuticals is a development-stage drug discovery company that targets the PI3K cell signaling pathways to create anti-cancer drugs.See details»
Semafore Pharmaceuticals Inc - Dun & Bradstreet
Company Description: Semafore Pharmaceuticals is signaling its arrival on the oncology drug making scene. The development-stage drug discovery company is targeting the PI3K cell โฆSee details»
Semafore Pharmaceuticals Inc - Company Profile and News
Company profile page for Semafore Pharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»
Semafore Pharmaceuticals Inc., Edward L. Jacobs,
[email protected]: Phone: 1-317-876-3075: Website: semaforepharma.com Fax: 1-317-876-3272: Summary ; Executive Details ; Board Members ; Business Information The โฆSee details»
Semafore Pharmaceuticals, Inc - VentureRadar
Semafore Pharmaceuticals, Inc VentureRadar profile. Find out more about Semafore Pharmaceuticals, Inc including the VentureRadar Innovation and Growth scores, Similar โฆSee details»
Semafore Pharmaceuticals Inc.
Mar 1, 2004 Semafore Pharmaceuticals Inc. (formerly ComChem Technologies) didn't start with a breakthrough scientific discovery. But the firm's founders encountered a unique opportunity โฆSee details»
Semafore Pharmaceuticals | www.inknowvation.com
Www.semaforepharma.com: Location: Single Congr. District: 05 County: Marion. Public Profile. Formerly known as ComChem Technologies and renamed as Semafore Pharmaceuticals in โฆSee details»
Semafore Pharmaceuticals - Products, Competitors, Financials, โฆ
Semafore Pharmaceuticals is a Healthcare/Pharmaceuticals / Drugs company based in Indianapolis, Indiana. Use the CB Insights Platform to explore Semafore Pharmaceuticals's full โฆSee details»
Semafore Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Explore Semafore Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, and 16 literature, Drug:SF-1126.See details»
Semafore Pharmaceuticals Inc. - careersinpharmaceutical.com
View Semafore Pharmaceuticals Inc. contact information in addition to a brief company description provided by CareersInPharmaceutical.comSee details»
Semafore Pharmaceuticals - Company Profile - BizStanding
On any company or organization. Login; Business Contacts & Backgrounds. Search. Business; Semafore Pharmaceuticals. Company Profile. Industry: Biotechnology. Company size: 11-50 โฆSee details»
Semafore Pharmaceuticals, Inc.:Company Profile & Technical โฆ
Semafore Pharmaceuticals, Inc. is a company that provides Drug, Oncology drugs, Multiple disorders and more. Semafore Pharmaceuticals, Inc. is headquartered in United States Indiana.See details»
Semafore Pharmaceuticals, Inc. Adds Former Eli Lilly and
Aug 1, 2006 CONTACT: Semafore Pharmaceuticals, Inc. - Derek A. Small, BusinessDevelopment & Regulatory Affairs, +1-317-876-3075; Media - Barbara Lindheimof โฆSee details»
Semafore Pharmaceuticals, Inc. Completes $9.5 Million Equity
Jan 5, 2007 CONTACT: Derek A. Small, Business Dev. & Regulatory Affairs of SemaforePharmaceuticals, Inc., +1-317-876-3075; Barbara Lindheim, โฆSee details»
Press Release: Semafore Pharmaceuticals Completes $9.5 Million โฆ
Jan 5, 2007 Semafore Pharmaceuticals Completes $9.5 Million Equity Financing - Raises More Than $13 Million from Combination of Series B Financing and Grant Awards as Company โฆSee details»
Richard Dimarchi - Semafore Pharmaceuticals Inc, Indianapolis
Found 25 colleagues at Semafore Pharmaceuticals Inc. There are 11 other people named Richard Dimarchi on AllPeople. Contact info: [email protected] Find more info โฆSee details»
Semafore Pharmaceuticals - CB Insights
Explore {Semafore Pharmaceuticals's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
semaforepharma.com Reviews | scam, legit or safe check
Check semaforepharma.com with our free review tool and find out if semaforepharma.com is legit and reliable. Need advice? Report scams Check Scamadviser! Report a Scam Help & Info API โฆSee details»
Semafore Pharmaceuticals, Inc. Completes $9.5 Million Equity
Jan 5, 2007 The company is preparing to initiate clinical trials for its lead clinical candidate, PI3K inhibitor SF1126. Semafore has also discovered the first drug-like small molecule PTEN โฆSee details»
Semafore Pharmaceuticals, Inc. (Semafore Pharmaceuticals, Inc.)
ไบ่งฃSemafore Pharmaceuticals, Inc. (Semafore Pharmaceuticals, Inc.)ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็1้กนไธดๅบ่ฏๅ8็ฏๆ็ฎ๏ผ่ฏ็ฉ:SF-1126๏ผSF2626ใSee details»